Evariste is quant biotech - we design better therapies for every patient using powerful AI tools...
At Evariste we have developed the novel concept of synthetic lethal gene signatures, small panels of multi-omic biomarkers which reveal untargeted synthetic lethal interactions together with the patient population for which drugs targeting these genes will be most effective...
We work in collaboration with biotech companies to accelerate the development of small molecules for a range of target classes in diverse disease areas. Our AI platform is able to support and advance discovery at every stage of preclinical development.